A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Intravenous Administration of IRX-010 in Healthy Participants
- First Posted Date
- 2024-04-10
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- ImmunoRx Pharma Inc.
- Target Recruit Count
- 83
- Registration Number
- NCT06356259
- Locations
- 🇳🇱
ICON, Groningen, Netherlands
© Copyright 2025. All Rights Reserved by MedPath